Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of William McLaughlin being referenced
Therapeutic applications of Auger and alpha emitting radionuclides.
1984
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| William McLaughlin | 272 | 118 | 78 | 87 | 22 | 380 | |
| R. G. Sephton | 213 | 88 | 13 | 106 | 26 | 371 | |
| Ephraim E. Parent | 270 | 48 | 29 | 211 | 41 | 452 | |
| James E. Carlton | 191 | 117 | 13 | 68 | 24 | 374 | |
| Linda S. Yasui | 141 | 250 | 20 | 75 | 28 | 420 | |
| K. G. Hofer | 220 | 229 | 12 | 139 | 27 | 458 | |
| Leonard Spolter | 107 | 158 | 27 | 20 | 29 | 439 | |
| Haibin Tian | 99 | 94 | 24 | 33 | 24 | 343 | |
| K Adams | 150 | 132 | 22 | 105 | 14 | 427 | |
| L. I. Wiebe | 193 | 91 | 25 | 64 | 17 | 432 | |
| A. Michałowski | 145 | 152 | 19 | 75 | 32 | 418 |
All Works
Loading papers...